查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
動物疼痛管理市場-按產品類型、應用、動物類型、地區和競爭對手分列的全球行業規模、份額、趨勢、機會和預測（2018-2028 年）
市場調查報告書
商品編碼
1244146

動物疼痛管理市場-按產品類型、應用、動物類型、地區和競爭對手分列的全球行業規模、份額、趨勢、機會和預測（2018-2028 年）

Veterinary Pain Management Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Product, By Application, By Animal Type, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 119 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球獸醫疼痛管理市場預計在預測期內將出現令人矚目的增長。

這是由於動物種群中炎症和疼痛性疾病（如缺陷、遺傳疾病和生理疾病）的發病率增加所致。 此外，城市地區對易於獲得和負擔得起的治療的需求不斷增長，以及動物健康和福利意識的提高正在推動世界各地對獸醫疼痛管理的需求，並顯著增加。 此外，越來越多的牲畜患有癌症、腹痛和神經性疼痛，這將增加對各種動物疼痛管理的需求，預計這將推動市場增長到 2028 年。 治療動物疼痛原因的研究和開發活動也有所增加，包括全球範圍內的各種治療方式，預計這將在預測期內進一步支持動物疼痛管理市場。 Veterinary Practice News 於 2020 年 6 月發表的一篇文章發現，全世界狗的骨關節炎患病率為 20%。 同樣，根據美國動物健康協會 2021 年 4 月發表的一篇文章，每年大約有 600 萬隻狗被診斷出患有癌症。

慢性病患病率增加

世界各地動物急性和慢性疾病發病率上升是預測期內推動市場增長的主要因素之一。 例如，動物缺乏症、遺傳疾病（包括遺傳和非遺傳疾病）和生理疾病等傳染病發病率的增加將在未來幾年積極推動市場的增長。我在這裡。 此外，由於包括傳染病在內的動物疾病日益流行，人們對獸醫疼痛管理療法的認識和需求不斷提高。 根據美國寵物用品協會 (APPA) 進行的 2021-2022 年全國寵物主人調查，70% 的美國家庭，即大約 9050 萬戶家庭擁有寵物。 同樣，門診診所越來越需要適應越來越多的外科手術，預計在預測期內將產生顯著增長。

增加對寵物保健的投資

在預測期內，更加註重改善寵物醫療設施和醫療基礎設施是推動獸醫疼痛管理市場增長的主要因素。 與公共機構和私營公司的戰略夥伴關係和合作越來越多，以開發和應用新技術和改進的技術。 這進一步擴大了未來幾年市場機會的多樣性。 此外，政府加大力度提高人們對早期診斷價值的認識，也再次提振了市場。 增加對醫療設備和設備的研發投資，特別是在發達和新興經濟體，將在預測期內進一步創造有利可圖的市場擴張前景。 2021 年美國投保的寵物總數將達到 390 萬隻，比 2020 年增長 28%。 非藥物疼痛管理技術的日益普及也是市場增長的主要驅動力，對用於疼痛管理的激光和電磁療法的需求不斷增長預計將推動市場增長多年。。

市場細分

近期發展

  • 2021 年 2 月，根據與 Animal Ethics Pty Ltd 的許可協議，Dechra Pharmaceuticals PLC 獲得了 Tri-Solfen 在澳大利亞和新西蘭的商業權利。 Tri-Solfen 被用作減輕家畜疼痛的常規藥物。
  • 2020 年 7 月，勃林格殷格翰收購了比利時生物技術公司 GST，以加強其在動物健康領域的干細胞能力。

市場進入者

Boehringer Ingelheim International GmbH、Zoetis Inc、Elanco Animal Health Incorporated、Norbrook Laboratories Limited、SeQuent Scientific Limited、Merck & Co. Inc、Decra Pharmaceuticals Plc、Vetoquinol S.A、Ceva Sante Animale SA、Chanelle Pharma Group Ltd 這是一個示例在疼痛管理市場經營的一些主要參與者。

範圍

這份報告將全球動物疼痛管理市場分為以下幾類，以及下面詳述的行業趨勢：

獸醫疼痛管理市場，按產品分類：

  • 藥物治療
  • 醫療設備

獸醫疼痛管理市場，按應用：

  • 關節痛
  • 癌痛
  • 術後疼痛
  • 其他

按動物類型劃分的動物疼痛管理市場：

  • 伴侶動物
  • 家畜

按地區劃分的獸醫疼痛管理市場：

  • 北美
    • 美國
    • 墨西哥
    • 加拿大
  • 歐洲
    • 法國
    • 德國
    • 英國
    • 意大利
    • 西班牙
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳大利亞
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
  • 中東和非洲
    • 南非
    • 沙特阿拉伯
    • 阿聯酋
    • 埃及
    • 土耳其人

競爭格局

公司簡介：對全球動物疼痛管理市場主要參與者的深入分析。

可自定義：

根據市場數據，TechSci Research 根據公司的具體需求提供定制服務。 該報告可以定制為：

公司信息

  • 對其他市場參與者（最多 5 家公司）進行深入分析和概況分析。

內容

第 1 章概述

  • 市場定義
  • 市場範圍
    • 目標市場
    • 研究目標年份
    • 主要市場細分

第二章研究方法論

  • 調查目的
  • 基線調查方法
  • 主要行業合作夥伴
  • 主要協會和次要信息
  • 調查方法
  • 數據三角測量和驗證
  • 假設和限制

第 3 章執行摘要

  • 市場概覽
  • 主要市場細分概述
  • 主要市場參與者概覽
  • 主要地區/國家概覽
  • 市場驅動因素、挑戰和趨勢概述

第 4 章 VOC（客戶之聲）

第 5 章全球動物疼痛管理市場展望

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按產品（藥品/醫療器械）
    • 按應用（關節痛、癌症疼痛、術後疼痛等）
    • 按動物類型（伴侶動物/家畜）
    • 按地區
    • 按公司分類（2022 年）
  • 市場地圖
    • 按產品分類
    • 通過申請
    • 按動物類型
    • 按地區

第 6 章北美動物疼痛管理市場展望

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按產品（藥品/醫療器械）
    • 按應用（關節痛、癌症疼痛、術後疼痛等）
    • 按動物類型（伴侶動物/家畜）
    • 按國家
  • 北美：國家/地區分析
    • 美國
    • 墨西哥
    • 加拿大

第 7 章歐洲動物疼痛管理市場展望

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按產品（藥品/醫療器械）
    • 按應用（關節痛、癌症疼痛、術後疼痛等）
    • 按動物類型（伴侶動物/家畜）
    • 按國家
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 意大利
    • 西班牙

第 8 章亞太動物疼痛管理市場展望

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按產品（藥品/醫療器械）
    • 按應用（關節痛、癌症疼痛、術後疼痛等）
    • 按動物類型（伴侶動物/家畜）
    • 按國家
  • 亞太地區：國家/地區分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳大利亞

第 9 章南美動物疼痛管理市場展望

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按產品（藥品/醫療器械）
    • 按應用（關節痛、癌症疼痛、術後疼痛等）
    • 按動物類型（伴侶動物/家畜）
    • 按國家
  • 南美洲：：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章中東和非洲動物疼痛管理市場展望

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按產品（藥品/醫療器械）
    • 按應用（關節痛、癌症疼痛、術後疼痛等）
    • 按動物類型（伴侶動物/家畜）
    • 按國家
  • MEA：國家分析
    • 南非動物的疼痛管理
    • 沙特阿拉伯獸醫疼痛管理
    • 阿聯酋獸醫疼痛管理
    • 埃及動物疼痛管理
    • 土耳其獸醫疼痛管理

第 11 章市場動態

  • 司機
  • 做

第12章市場趨勢與發展

  • 近期趨勢
  • M&A（併購）
  • 產品發布

第13章競爭格局

  • Business Overview
  • Product Offerings
  • Recent Developments
  • Financials（As Reported）
  • Key Personnel
  • SWOT Analysis
    • Boehringer Ingelheim International GmbH
    • Zoetis Inc.
    • Elanco Animal Health Incorporated
    • Norbrook Laboratories Limited
    • SeQuent Scientific Limited
    • Merck & Co., Inc.
    • Dechra Pharmaceuticals Plc
    • Vetoquinol S.A.
    • Ceva Sante Animale SA
    • Chanelle Pharma Group Ltd.

第14章 戰略建議

簡介目錄
Product Code: 14422

Global veterinary pain management market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing incidence of inflammatory and painful diseases such as deficiency disease, hereditary diseases, and physiological diseases in the animal population. Additionally, growing the need for easily accessible and affordable treatment procedures in urban regions and growing awareness about animal health and welfare have significantly enhanced the demand for veterinary pain management across different parts of the globe. Additionally, increasing the livestock population suffering from cancer, abdominal pain, and neuropathic pain is expected to boost the demand for different veterinary pain management, thereby fuelling the market growth through 2028. Besides, increasing research and development activities to treat various causes of pain in animals including different therapy across the globe is further expected to support the veterinary pain management market during the forecast period. According to an article published by Veterinary Practice News in June 2020, the prevalence of osteoarthritis in dogs was found to be 20% globally. Similarly, according to an article published by American Animal Health Association in April 2021, approximately 6 million dogs are diagnosed with cancer each year.

Growing Prevalence of Chronic Diseases

The increasing rate of acute and chronic diseases in animals across the globe is one of the major factors bolstering the growth of the market in the forecast period. For example, the growing incidence rate of infectious diseases such as deficiency diseases, hereditary diseases (including both genetic diseases and non-genetic hereditary diseases), and physiological diseases in animals is positively enhancing the growth of the market over the coming years. Also, due to the increasing prevalence of animal diseases which also includes epizootic diseases, there is a greater awareness and rising need for veterinary pain management therapy. Seventy percent of U.S. households, or about 90.5 million families, own a pet, according to the 2021-2022 National Pet Owners Survey conducted by the American Pet Products Association (APPA). Similarly, the growing need for outpatient clinics to meet the rising volume of surgical procedures is expected to create significant growth during the forecasted period.

Increasing Investment in the Pet Healthcare Sector

Growing focus on improving the pet healthcare facilities and overall healthcare infrastructure is a major factor boosting the growth of the veterinary pain management market in the forecast period. To develop and apply new and improved technologies, there are an increasing number of strategic partnerships and collaborations with both public and private organizations. This is further expanding the diversity of market opportunities for the coming years. Additionally, the government's rising efforts to raise awareness of the value of early diagnosis are once again fuelling the market's expansion. Increasing investment in R&D, particularly in established and developing economies, about medical instruments and devices will further generate profitable market expansion prospects over the projection period. The total number of pets insured in the U.S. in 2021 was 3.9 million, a 28 percent increase since 2020. Also, the growing popularity of nonpharmaceutical pain management techniques is a major factor in the growth of the market, and the growing demand for laser therapy and electromagnetic therapy as pain management is anticipated to drive the growth of the market over the years.

Market Segmentation

Global veterinary pain management market can be segmented by product, application, animal type, and by region. Based on product, the market can be divided into Medications and Medical Devices. Based on application, the market can be differentiated into Joint Pain, Cancer Pain, Postoperative Pain, and Others. Based on application, the market can be divided into Companion Animals and Livestock animals. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East and Africa, and South America. Among the different countries, United States dominated the global veterinary pain management market on account of the growing incidence of animal diseases in the country.

Recent Development

  • In February 2021, Dechra Pharmaceuticals PLC received rights for marketing Tri-Solfen in Australia and New Zealand under a licensing agreement with Animal Ethics Pty Ltd. Tri-Solfen is used as a routine treatment in reducing pain for farm animals.
  • In July 2020, Boehringer Ingelheim acquired a Belgian biotech company, GST, to strengthen its stem cell capabilities in the Animal Health segment.

Market Players

Boehringer Ingelheim International GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Norbrook Laboratories Limited, SeQuent Scientific Limited, Merck & Co., Inc., Dechra Pharmaceuticals Plc, Vetoquinol S.A., Ceva Sante Animale SA, Chanelle Pharma Group Ltd are some of the leading players operating in the global veterinary pain management market.

Report Scope:

In this report, global veterinary pain management market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Pain Management Market, By Product:

  • Medications
  • Medical Devices

Veterinary Pain Management Market, By Application:

  • Joint Pain
  • Cancer Pain
  • Postoperative Pain
  • Others

Veterinary Pain Management Market, By Animal Type:

  • Companion Animal
  • Livestock Animal

Veterinary Pain Management Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Veterinary Pain Management Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary Pain Management Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Medications v/s Medical Devices)
      • 5.2.1.1. By Medication (NSAIDS, Opioids, Local anaesthetics, Alpha-2 agonists, Others)
      • 5.2.1.2. By Medical Devices (Laser Therapy Device v/s Electromagnetic Device)
    • 5.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
    • 5.2.3. By Animal Type (Companion Animal v/s Livestock Animal)
      • 5.2.3.1. By Companion Animal (Dog, Cat, Horse, Others)
      • 5.2.3.2. By Livestock Animal (Cattle, Swine, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2022)
  • 5.3. Market Map
    • 5.3.1. By Product
    • 5.3.2. By Application
    • 5.3.3. By Animal Type
    • 5.3.4. By Region

6. North America Veterinary Pain Management Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Medications v/s Medical Devices)
      • 6.2.1.1. By Medication (NSAIDS, Opioids, Local anaesthetics, Alpha-2 agonists, Others)
      • 6.2.1.2. By Medical Devices (Laser Therapy Device v/s Electromagnetic Device)
    • 6.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
    • 6.2.3. By Animal Type (Companion Animal v/s Livestock Animal)
      • 6.2.3.1. By Companion Animal (Dog, Cat, Horse, Others)
      • 6.2.3.2. By Livestock Animal (Cattle, Swine, Others)
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Veterinary Pain Management Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By Animal Type
    • 6.3.2. Mexico Veterinary Pain Management Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By Animal Type
    • 6.3.3. Canada Veterinary Pain Management Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By Animal Type

7. Europe Veterinary Pain Management Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product (Medications v/s Medical Devices)
      • 7.2.1.1. By Medication (NSAIDS, Opioids, Local anaesthetics, Alpha-2 agonists, Others)
      • 7.2.1.2. By Medical Devices (Laser Therapy Device v/s Electromagnetic Device)
    • 7.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
    • 7.2.3. By Animal Type (Companion Animal v/s Livestock Animal)
      • 7.2.3.1. By Companion Animal (Dog, Cat, Horse, Others)
      • 7.2.3.2. By Livestock Animal (Cattle, Swine, Others)
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Veterinary Pain Management Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By Animal Type
    • 7.3.2. Germany Veterinary Pain Management Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By Animal Type
    • 7.3.3. United Kingdom Veterinary Pain Management Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By Animal Type
    • 7.3.4. Italy Veterinary Pain Management Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By Animal Type
    • 7.3.5. Spain Veterinary Pain Management Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By Animal Type

8. Asia-Pacific Veterinary Pain Management Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product (Medications v/s Medical Devices)
      • 8.2.1.1. By Medication (NSAIDS, Opioids, Local anaesthetics, Alpha-2 agonists, Others)
      • 8.2.1.2. By Medical Devices (Laser Therapy Device v/s Electromagnetic Device)
    • 8.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
    • 8.2.3. By Animal Type (Companion Animal v/s Livestock Animal)
      • 8.2.3.1. By Companion Animal (Dog, Cat, Horse, Others)
      • 8.2.3.2. By Livestock Animal (Cattle, Swine, Others)
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Veterinary Pain Management Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By Animal Type
    • 8.3.2. India Veterinary Pain Management Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By Animal Type
    • 8.3.3. South Korea Veterinary Pain Management Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By Animal Type
    • 8.3.4. Japan Veterinary Pain Management Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By Animal Type
    • 8.3.5. Australia Veterinary Pain Management Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By Animal Type

9. South America Veterinary Pain Management Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product (Medications v/s Medical Devices)
      • 9.2.1.1. By Medication (NSAIDS, Opioids, Local anaesthetics, Alpha-2 agonists, Others)
      • 9.2.1.2. By Medical Devices (Laser Therapy Device v/s Electromagnetic Device)
    • 9.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
    • 9.2.3. By Animal Type (Companion Animal v/s Livestock Animal)
      • 9.2.3.1. By Companion Animal (Dog, Cat, Horse, Others)
      • 9.2.3.2. By Livestock Animal (Cattle, Swine, Others)
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Veterinary Pain Management Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By Animal Type
    • 9.3.2. Argentina Veterinary Pain Management Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By Animal Type
    • 9.3.3. Colombia Veterinary Pain Management Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By Animal Type

10. Middle East and Africa Veterinary Pain Management Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product (Medications v/s Medical Devices)
      • 10.2.1.1. By Medication (NSAIDS, Opioids, Local anaesthetics, Alpha-2 agonists, Others)
      • 10.2.1.2. By Medical Devices (Laser Therapy Device v/s Electromagnetic Device)
    • 10.2.2. By Application (Joint Pain, Cancer Pain, Postoperative Pain, Others)
    • 10.2.3. By Animal Type (Companion Animal v/s Livestock Animal)
      • 10.2.3.1. By Companion Animal (Dog, Cat, Horse, Others)
      • 10.2.3.2. By Livestock Animal (Cattle, Swine, Others)
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Veterinary Pain Management Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Animal Type
    • 10.3.2. Saudi Arabia Veterinary Pain Management Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Animal Type
    • 10.3.3. UAE Veterinary Pain Management Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Animal Type
    • 10.3.4. Egypt Veterinary Pain Management Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Product
        • 10.3.4.2.2. By Application
        • 10.3.4.2.3. By Animal Type
    • 10.3.5. Turkey Veterinary Pain Management Market Outlook
      • 10.3.5.1. Market Size & Forecast
        • 10.3.5.1.1. By Value
      • 10.3.5.2. Market Share & Forecast
        • 10.3.5.2.1. By Product
        • 10.3.5.2.2. By Application
        • 10.3.5.2.3. By Animal Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Competitive Landscape

  • 13.1. Business Overview
  • 13.2. Product Offerings
  • 13.3. Recent Developments
  • 13.4. Financials (As Reported)
  • 13.5. Key Personnel
  • 13.6. SWOT Analysis
    • 13.6.1. Boehringer Ingelheim International GmbH
    • 13.6.2. Zoetis Inc.
    • 13.6.3. Elanco Animal Health Incorporated
    • 13.6.4. Norbrook Laboratories Limited
    • 13.6.5. SeQuent Scientific Limited
    • 13.6.6. Merck & Co., Inc.
    • 13.6.7. Dechra Pharmaceuticals Plc
    • 13.6.8. Vetoquinol S.A.
    • 13.6.9. Ceva Sante Animale SA
    • 13.6.10. Chanelle Pharma Group Ltd.

14. Strategic Recommendations